Related references
Note: Only part of the references are listed.Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2021)
Metallo-β-lactamase resistance in Enterobacteriaceae is an artefact of currently utilized antimicrobial susceptibility testing methods
Tomefa E. Asempa et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans
Jurgen B. Bulitta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
In Vivo Pharmacodynamic Profile of Ceftibuten-Clavulanate Combination against Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in the Murine Thigh Infection Model
Kamilia Abdelraouf et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
In Vivo Efficacy of WCK 5222 (Cefepime-Zidebactam) against Multidrug-Resistant Pseudomonas aeruginosa in the Neutropenic Murine Thigh Infection Model
Marguerite L. Monogue et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Single-Center Evaluation of the Pharmacokinetics of WCK 5222 (Cefepime-Zidebactam Combination) in Subjects with Renal Impairment
Richard A. Preston et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
In Vivo Efficacy of Humanized WCK 5222 (Cefepime-Zidebactam) Exposures against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Thigh Model
Safa S. Almarzoky Abuhussain et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy
Anne H. Norris et al.
CLINICAL INFECTIOUS DISEASES (2019)
Treatment of Infections by OXA-48-Producing Enterobacteriaceae
Adam Stewart et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Assessment of the In Vivo Efficacy of WCK 5222 (Cefepime-Zidebactam) against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Murine Lung Infection Model
Lindsay M. Avery et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteria
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates
Bartolome Moya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent β-Lactam Enhancer Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones
Bartolome Moya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Mechanisms of ertapenem resistance in Enterobacteriaceae isolates in a tertiary university hospital
Hae-Sun Chung et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
Safety and Efficacy of Long-Term Outpatient Ertapenem Therapy
Zubair A. Qureshi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Impact of various conditions on the efficacy of dual carbapenem therapy against KPC-producing Klebsiella pneumoniae
Dora E. Wiskirchen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Susceptibility of Klebsiella pneumoniae Isolates from Intra-Abdominal Infections and Molecular Characterization of Ertapenem-Resistant Isolates
Stephen P. Hawser et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
In Vivo Efficacy of a Human-Simulated Regimen of Ceftaroline Combined with NXL104 against Extended-Spectrum-β-Lactamase (ESBL)-Producing and Non-ESBL-Producing Enterobacteriaceae
Dora E. Wiskirchen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Change in antipseudomonal carbapenem susceptibility in 25 hospitals across 9 years is not associated with the use of ertapenem
Kathryn J. Eagye et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrump-β-lactamase-producing Gram-negative organisms
Rohit Bazaz et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Pharmacokinetics of ertapenem in healthy young volunteers
AK Majumdar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Share Paper
